Intervention not reported
SAEs ‐ formoterol versus placebo ( · patients with chronic asthma
The intervention leads to higher SAEs ‐ formoterol versus placebo ( (high certainty).
1 finding from 1 review
Intervention not reported
SAEs ‐ formoterol versus salbutamol ( · patients with chronic asthma
The intervention showed no clear difference in SAEs ‐ formoterol versus salbutamol ( (moderate certainty).
1 finding from 1 review
Intervention not reported
Mortality (all‐cause) ‐ formoterol versus placebo ( · patients with chronic asthma
The intervention showed no clear difference in mortality (all‐cause) ‐ formoterol versus placebo ( (moderate certainty).
1 finding from 1 review
Intervention not reported
Mortality (all‐cause) ‐ formoterol versus salbutamol ( · patients with chronic asthma
The intervention showed no clear difference in mortality (all‐cause) ‐ formoterol versus salbutamol ( (moderate certainty).
1 finding from 1 review
Intervention not reported
SAEs ‐ formoterol versus placebo ( · patients with chronic asthma (children)
The intervention leads to higher SAEs ‐ formoterol versus placebo ( (high certainty).
1 finding from 1 review
Intervention not reported
SAEs ‐ formoterol versus salbutamol · patients with chronic asthma (children)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality in adults · people with asthma
1 finding from 1 review
All‐cause mortality in children · people with asthma
1 finding from 1 review
All‐cause SAEs in adults · people with asthma
Regular formoterol showed no clear difference in all‐cause SAEs in adults compared with regular salmeterol (low certainty).
1 finding from 1 review
All‐cause SAEs in children · people with asthma
It is very uncertain whether regular formoterol changes all‐cause SAEs in children compared with regular salmeterol (very low certainty).
1 finding from 1 review
Asthma‐related SAE ‐ Adults · people with asthma
Regular formoterol showed no clear difference in asthma‐related SAEs in adults compared with regular salmeterol (low certainty).
1 finding from 1 review
Asthma‐related SAE ‐ Children · people with asthma
1 finding from 1 review
Dyspnoea during exercise Modified Borg dyspnoea score at end of 6‐minute walk test Scores range from 0 to 10, with lower scores indicating less shortness of breath · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Change in 6‐minute walking distance · patients with chronic obstructive pulmonary disease
1 finding from 1 review
QoL · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Dyspnoea during exercise Modified Borg dyspnoea score at end of 6‐minute walk test Scores range from 0 to 10, with lower scores indicating less shortness of breath · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Dyspnea · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Exercise endurance Duration of constant work rate exercise test (minutes) · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Exercise endurance Duration of constant work rate exercise test on treadmill · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Change in 6‐minute walking distance · patients with chronic obstructive pulmonary disease
1 finding from 1 review